期刊文献+

人CD59基因克隆、原核表达及其多克隆抗体的制备

Clone,prokaryotic expression and pre-paration of polyclonal antibody of hCD59
下载PDF
导出
摘要 目的:构建人CD59真核及原核表达质粒,并制备抗人CD59多克隆抗体,以用于研究糖蛋白CD59生物学功能。方法:用RT-PCR技术从人PBMCs中获取hCD59全长及其胞外区hsCD59cDNA序列,分别克隆至pVAX-1真核表达载体及pGEX-KG原核表达载体。重组融合蛋白GST-hsCD59由经IPTG诱导的大肠杆菌BL21表达后纯化并鉴定。用pVAX-1-hCD59质粒免疫家兔并用纯化的GST-hsCD59融合蛋白加强免疫制备兔抗人CD59多克隆抗体并测定其效价。结果:成功构建人CD59真核表达质粒pVAX-1-hCD59和原核表达质粒pGEX-KG-hsCD59。融合蛋白GST-hsCD59在大肠杆菌中高效表达,表达产物的相对分子质量(Mr)同预期值一致。制备的兔抗人CD59多克隆抗体效价为1∶3200。结论:成功地构建了重组真核表达质粒pVAX-1-hCD59及原核表达质粒pGEX-KG-hsCD59,获得了兔抗人CD59多克隆抗体,这将有助于我们深入研究CD59在人类疾病中的生物学功能。 AIM: To construct full length hCD59 eukaryotic and extracellular domain of hCD59(hsCDS9) prokaryotic expression vectors and prepare polyclonal antibody of hCD59. METHODS: cDNA fragments encoding hCD59 and hsCD59 were amplified from human PBMCs by RT-PCR and cloned into the eukaryotic vector pVAX-1 and prokaryotic vector pGEX-KG, respectively. The recombinant fusion protein GST-hsCD59 was expressed in E. coil BL21 induced by IPTG. Then the fusion protein was purified and identified. Polyclonal antibody against hCD59 was prepared by immuni- zing rabbit with pVAX-1-hCD59 and boosting with GST- hsCD59 fusion protein, and the titer was identified. RE- SULTS: The recombinant eukaryotic vector pVAX-1-hCD59 and prokaryotic vector pGEX-KG-hsCD59 were successfully constructed. The GST-hsCD59 fusion protein was over-expressed in E. coli BL21 and the relative molecular mass (Mτ) of the expression product was identical with predicted size. The titer of the anti-hCD59 serum was 1:3 2,00. CONCLUSION: We got the recombinant eukaryotic vector pVAX-1-hCD59, prokaryotic vector pGEX-KG-hsCD59 and rabbit anti-hCD59 polyclonal antibody successfully. These work would be helpful for the further study of the biological function of human CD59.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2009年第10期924-926,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家重大传染病专项基金资助(2008ZX10003-005)
关键词 人CD59 克隆 多克隆抗体 human CD59 cloning polyclonal antibody
  • 相关文献

参考文献3

二级参考文献37

  • 1张艳丽,高美华.人CD59基因的突变和表达及其活性研究[J].细胞与分子免疫学杂志,2005,21(2):151-154. 被引量:6
  • 2任书荣,高美华.突变人CD59分子糖基化前后抗补体活性的变化[J].中国动脉硬化杂志,2006,14(1):9-12. 被引量:1
  • 3Hensel F,Hermann R,Brandlein S,et al.Regulation of the new coexpressed CD55 (decay-accelerating factor) receptor on stomach carcinoma cells involved in antibody SC-1-induced apopzosis[J].Lab Invest,2001,81 (11):1553-1563.
  • 4Gelderman K A,Hakulinen J,Hagenaars M,et al.Membrane-bound complement regulatory proteins inhibit complement activation by an immunotherapeutic mAb in a syngeneic rat colorectal cancer model[J].Mol Immunol,2003,40(1):13-23.
  • 5Gelderman K A,Kuppen P J,Okada N,et al.Tumor-specific inhibition of membrane-bound complement regulatory protein Crry with bispecific monoclonal antibodies prevents tumor outgrowth in a rat colorectal cancer lung metastases model[J].Cancer Res,2004,64 (12):4366-4372.
  • 6Imai M,Ohta R,Okada N,et al.Inhibition of a complement regulator in vivo enhances antibody therapy in a model of mammary adenocarcinoma[J].Int J Cancer,2004,110(6):875-881.
  • 7Jurianz K,Maslak S,Garcia-Schuler H,et al.Neutralization of complement regulatory proteins augments lysis of breast carcinoma cells targeted with rhumAb anti-HER2[J].Immunopharmacology,1999,42 (1-3):209-218.
  • 8Andoh A,Shimada M,Araki Y,et al.Sodium butyrate enhances complement-mediated cell injury via down-regulation of decay-accelerating factor expression in colonic cancer cells[J].Cancer Immunol Immunother,2002,50 (12):663-672.
  • 9Pritchard-Jones K,Spendlove I,Wilton C,et al.Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy,for osteosarcoma[J].Br J Cancer,2005,92(8):1358-1365.
  • 10Madjd Z,Durrant L G,Pinder S E,et al.Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)?[J].Cancer Immunol Immunother,2005,54(2):149-156.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部